Cannabinoid receptor-1 antagonist inhibits morphine tolerance in rats with inflammatory pain

GUO Qian,JIA Lijie,WANG Lai,JIA Chenfei,XUE Qingsheng,YU Buwei

2013-01-01

Abstract:Objective To observe changes of cannabinoid receptor-1 (CB1) protein expression in spinal dorsal horn of morphine tolerant rats with inflammatory pain so as to explore the effect of CB1 antagonist in the process of morphine tolerance. Methods Forty male adult Sprague-Dawley rats with intrathecal catheters implanted successfully were randomly divided into four groups(n=10). In control group, 100 μL normal saline were injected by right metapodium and 3 days later 10 μL saline were given again. In CFA group, 100 μL complete Freund adjuvant (CFA) were injected by right metapodium and 3 days later 10 μL saline were given. In Mor group, 100 μL CFA were injected by right metapodium and 3 days later 10 μg/μL morphine were given. In AM251 group, 100 μL CFA were injected by right metapodium and 3 days later 10 μg morphine and 5 nmol(10 μL) AM251 were given for 7 d. Then the rats were sacrificed at the 8th day. Heat hyperalgesia was evaluated by paw withdrawal thermal latency (PWTL). The expression of CB1 in spinal L2-L4 was detected by Western blotting. Results The PWTL after CFA administration were significantly lower than before CFA administration in the CFA group, Mor group and AM251 group (all P<0.001). There was no significant difference in PWTL 1, 3, 5, or 7 d after CFA administration in the CFA group (all P>0.05). The PWTL in Mor group was significantly higher than that in CFA group 1, 2,3 and 5 d after CFA administration (all P<0.001), and the difference was not statistically significant on day 7 after CFA administration between the two groups (P>0.05). The PWTL in the AM251 group maintained at a high level on day 1, 3, 5, and 7 after CFA administration and the differences of PWTL at each time point were not statistically significant (all P>0.05). The expression of CB1 in Mor group was significantly higher than those in control group (P<0.001) and CFA group (P<0.05) after development of morphine tolerance. Conclusion CB1 antagonist AM251 can inhibit the development of morphine tolerance.